Ledipasvir/sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; 
dulaglutide (Trulicity) for glycemic control in type-2 diabetes; 
netupitant/palonosetron (Akynzeo) for prevention of nausea and vomiting related 
to chemotherapy; and naloxegol (Movantik) for opioid-induced constipation in 
patients with chronic noncancer pain.